Skip to main content
Obesity Medicine1 May 20268 min read

Normal BMI, Hidden Risk: Why Standard Checkups Miss Metabolic Disease in Indian Adults

India's largest national diabetes survey found that 43.3% of normal-weight Indian adults carry serious metabolic risk their annual checkup won't catch. Standard panels miss fasting insulin, LDL particle size, and visceral fat, the markers that matter. Here's what the evidence shows.

Illustration showing hidden metabolic risk in adults with a normal BMI.

Key Takeaways

India's ICMR-INDIAB study found that 43.3% of normal-weight Indian adults have the MONO phenotype, serious metabolic risk despite a healthy BMI. Standard annual checkups in India do not screen for this. The tests that reveal it, fasting insulin, waist-to-hip ratio, uric acid, liver enzymes, are rarely ordered. If you have a family history of diabetes, abdominal weight gain, or lipid results at the edge of normal, a fuller assessment is worth discussing with your doctor.

A familiar scene at the doctor's office

Ravi is 48 years old. He has had an annual health check every year without fail. His weight is normal. His BMI, the number doctors use to judge whether someone is overweight, sits comfortably in the healthy range. His fasting blood sugar came back normal. His blood pressure was fine. His doctor looked at the results, said he was in good shape, and sent him home.

Six months later, Ravi was diagnosed with fatty liver disease. His insulin was not working properly. His triglycerides, fats circulating in the blood, were high. He had metabolic syndrome, a cluster of conditions that raise the risk of heart disease, stroke, and type 2 diabetes, without anyone catching it.

Ravi is not unusual. Research now shows that millions of Indian adults with a normal body weight carry serious metabolic risk that standard annual checkups do not detect.

What the evidence says

The MONO phenotype: metabolic obesity with a normal BMI

Researchers have a name for what happened to Ravi: metabolically obese, normal weight, or the MONO phenotype. A person with MONO has a normal BMI but carries excess fat stored around the organs inside the abdomen. This is visceral fat. It is not visible from the outside. It does not show up on a weighing scale. But it is metabolically active, it produces inflammatory signals and interferes with how the body processes insulin. The result is the same metabolic damage associated with obesity, but with no outward warning.

India's largest national survey of diabetes and metabolic conditions, the ICMR-INDIAB study, conducted by the Indian Council of Medical Research, found that 43.3% of normal-weight Indian adults have the MONO phenotype. Nearly half of Indian adults who look metabolically healthy by BMI are not. That is not a small statistical footnote. It is a structural feature of how metabolic disease presents in the Indian population.

43.3% of normal-weight Indian adults carry significant metabolic risk that a standard annual checkup will not catch. Source: ICMR-INDIAB study, Lancet Diabetes & Endocrinology, 2023.

Get Started

Why Indian adults are particularly vulnerable

Indian adults tend to carry more body fat at lower body weights compared to people of European descent. The relationship between BMI and actual body fat percentage is different. This is established clearly enough that Indian clinical guidelines use lower BMI cutoff points. The Indian threshold for overweight is a BMI of 23, not 25, as international guidelines set it. The threshold for obesity is 25, not 30. A person with a BMI of 24 would appear to be at a normal weight on international charts, but be classified as overweight by Indian standards and potentially already at metabolic risk.

Standard annual checkups in India, including those run under the National Programme for Non-Communicable Diseases, screen for diabetes, hypertension, and abdominal obesity. They do not screen for metabolic syndrome as a combined condition. Dyslipidaemia, abnormal blood fat levels such as high triglycerides or low HDL cholesterol, is not routinely checked in public primary care settings. This means the tests most people receive miss the very markers that would reveal metabolic disease in a normal-weight person.

How large is the undiagnosed burden?

The ICMR-INDIAB study also found that nearly 40% of Indian adults with diabetes and hypertension are undiagnosed, they have the condition, but do not know it, because the tests that would reveal it were never ordered. A 2024 study published in International Health (Oxford Academic) examined metabolic risk specifically in Delhi and found high rates of undiagnosed metabolic risk even among people who had recently accessed health services. The gap is not only about access, it is about what gets checked during a visit.

What about cholesterol and blood fats?

A standard cholesterol test gives total cholesterol, LDL, HDL, and triglycerides. But LDL cholesterol is not a single uniform substance, it comes in different particle sizes. Small, dense LDL particles are more likely to deposit in artery walls than larger, buoyant ones. Two people can have the same LDL number but very different actual cardiovascular risk depending on particle size. A cardiology specialist review of lipid panels goes into exactly these distinctions.

Uric acid levels, not routinely checked in annual blood panels, are independently associated with insulin resistance and metabolic syndrome. Elevated liver enzymes can point to early fatty liver disease, which is closely linked to metabolic dysfunction. Both are inexpensive tests. Neither is standard.

What this means for your case

If you or a family member has a normal BMI but any of the following applies, the research above is directly relevant:

  • check_circleA family history of type 2 diabetes or heart disease
  • check_circleAbdominal weight gain, even if the overall BMI is normal
  • check_circlePersistent fatigue without a clear cause
  • check_circleFasting blood sugar that is trending upward year on year, even if still within the normal range
  • check_circleTriglycerides at the high end of normal, or HDL cholesterol at the low end of normal
  • check_circleA diagnosis of fatty liver disease
  • check_circleA history of gestational diabetes

The question worth asking your doctor is not just: "Is my BMI normal?" It is: "Has my metabolic health been assessed thoroughly?" Specific questions worth raising:

  • check_circleHas my waist circumference been measured and compared to Indian-specific guidelines?
  • check_circleHas my fasting insulin been tested, not just my fasting blood sugar?
  • check_circleHas my full lipid panel been checked, including triglycerides and HDL?
  • check_circleDo my liver enzyme results suggest any early changes worth looking into further?

What a subspecialist review evaluates

When a board-certified endocrinologist or obesity medicine physician reviews a patient for metabolic risk, they look well beyond a standard annual check. Clinical literature on thorough metabolic assessment identifies the following markers as relevant:

  • check_circleHOMA-IR: a calculation that estimates how effectively the body is using insulin. Fasting blood sugar alone does not catch insulin resistance.
  • check_circleWaist-to-hip ratio: a more accurate indicator of visceral fat distribution than BMI or waist circumference alone.
  • check_circleDEXA scan: an imaging test that measures actual body fat percentage and how it is distributed, including visceral versus subcutaneous fat.
  • check_circleFull lipid panel: triglycerides, HDL, LDL particle size, assessed together rather than as isolated numbers.
  • check_circleUric acid: elevated levels are independently linked to insulin resistance and cardiovascular risk.
  • check_circleLiver enzymes (ALT, AST): raised levels can signal non-alcoholic fatty liver disease, which is closely linked to metabolic syndrome.
  • check_circlehs-CRP (high-sensitivity C-reactive protein): a marker of low-grade inflammation, associated with both metabolic syndrome and cardiovascular risk.

A specialist review does not simply add more numbers. It interprets these markers together, in the context of the patient's full history, to produce a coherent picture of actual metabolic risk.

Getting a more complete picture

A normal BMI is reassuring. It is not the whole story. For Indian adults, particularly those over 35 with a family history of diabetes, heart disease, or abdominal weight gain, the evidence is clear: metabolic risk can be present and active long before a standard health check catches it.

An educational medical review by a U.S. board-certified endocrinologist or obesity medicine specialist can evaluate your existing reports, identify what tests are missing, and give you a written assessment of what your results actually mean in the context of current clinical guidelines. This is not a substitute for an in-person physician relationship, it is a second perspective, one that draws on subspecialist expertise that may not be available through a routine consultation.

This article is for educational purposes only. It does not constitute a medical diagnosis or treatment recommendation. It does not replace an in-person physician relationship. If you are experiencing a medical emergency, call your local emergency services immediately.

Frequently Asked Questions

What is the MONO phenotype and why does it matter for Indians?

expand_more

MONO stands for metabolically obese, normal weight. It describes someone with a normal BMI who carries excess fat stored around the organs inside the abdomen, visceral fat. This fat is metabolically active and creates the same disease risk as obesity, but without any outward signs. India's ICMR-INDIAB study found 43.3% of normal-weight Indian adults have this phenotype, making it a major undetected health risk.

My BMI is normal. Do I still need metabolic testing?

expand_more

Possibly, especially if you have a family history of diabetes or heart disease, abdominal weight gain, fasting blood sugar trending upward, triglycerides at the high end of normal, or low HDL cholesterol. Indian clinical guidelines use lower BMI cutoffs than international standards, overweight begins at BMI 23, not 25. A thorough metabolic assessment looks beyond BMI at markers like fasting insulin, waist-to-hip ratio, and a full lipid panel.

What is the difference between fasting blood sugar and fasting insulin?

expand_more

Fasting blood sugar tells you the level of glucose in your blood at a single point in time. Fasting insulin tells you how hard your body is working to keep that glucose under control. HOMA-IR, a calculation using both numbers, estimates insulin resistance, which can be present and damaging for years before blood sugar rises into the diabetic range. Standard checkups measure blood sugar; they rarely measure insulin.

Can I have metabolic syndrome without being overweight?

expand_more

Yes. Metabolic syndrome is a cluster of conditions, high triglycerides, low HDL cholesterol, elevated blood pressure, high fasting blood sugar, and excess abdominal fat, and it can be present even when BMI appears normal. For Indian adults, the ICMR-INDIAB study confirmed this is not rare: it affects a significant proportion of the population at weights that international charts would classify as healthy.

What additional tests would a specialist order to assess metabolic risk?

expand_more

Beyond the standard panel, a thorough metabolic assessment typically includes: HOMA-IR (insulin resistance estimate), waist-to-hip ratio, a full lipid panel including triglycerides and HDL, uric acid levels, liver enzymes (ALT, AST), and hs-CRP (high-sensitivity C-reactive protein). A DEXA scan can measure actual body fat percentage and visceral fat distribution. These are the markers that reveal what a standard annual checkup misses.

Ready to get a U.S. specialist's view of your case?

Get an Obesity Medicine Second Opinion

Ready for an Expert Second Opinion?

Connect with U.S. board-certified specialists for an independent written review of your case — delivered in 14 days, no travel required.